- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01473966
Coffee Against Obstipation in Intensive Care Treatment
November 14, 2011 updated by: Christoph Eisenbach, University Hospital Heidelberg
Coffee might stimulate bowel movement and thus overcome obstipation in intensive care unit (ICU) patients.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Critically ill patients requiring ventilator support frequently suffer from obstipation.
We hypothesize that coffee, administered either orally or rectally, might stimulate bowel movement.
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Heidelberg, Germany, 69120
- University Hospital of Heidelberg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- admission to the medical intensive care unit of the Dept. of Gastroenterology at the university hospital heidelberg
- requires ventilator support for an anticipated more than 72 hours
- age older than 18 years
Exclusion Criteria:
- pregnancy
- known allergy to coffee
- mechanical ileus
- presence of enterostoma
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: standard of care
patients receive standard care
|
|
Experimental: Coffee orally
patients will receive standard of care plus coffee orally
|
patients will receive a cup of coffee at room temperature orally twice daily
|
Experimental: coffee rectally
patients receive standard of care plus coffee rectally
|
patients receive an enema of two cups of coffee at room temperature once daily
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Bowel movement rate
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 5 weeks
|
participants will be followed for the duration of hospital stay, an expected average of 5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
time on mechanical ventilation
Time Frame: participants will be followed for the duration of intensive care unit stay, an expected average of 3 weeks
|
participants will be followed for the duration of intensive care unit stay, an expected average of 3 weeks
|
time of stay on ICU
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 5 weeks
|
participants will be followed for the duration of hospital stay, an expected average of 5 weeks
|
lengths of hospitalisation
Time Frame: an average of 5 weeks of hospital stay is expected
|
an average of 5 weeks of hospital stay is expected
|
in hospital mortality
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 5 weeks
|
participants will be followed for the duration of hospital stay, an expected average of 5 weeks
|
long term mortality
Time Frame: 6 months following discharge
|
6 months following discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christoph Eisenbach, University of Heidelberg, Heidelberg, Germany
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2011
Primary Completion (Anticipated)
December 1, 2013
Study Completion (Anticipated)
June 1, 2014
Study Registration Dates
First Submitted
November 10, 2011
First Submitted That Met QC Criteria
November 14, 2011
First Posted (Estimate)
November 17, 2011
Study Record Updates
Last Update Posted (Estimate)
November 17, 2011
Last Update Submitted That Met QC Criteria
November 14, 2011
Last Verified
November 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- COFFEE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstipation
-
dr. schwandnerUnknown
Clinical Trials on coffee
-
University of California, San FranciscoRecruiting
-
Mondelēz International, Inc.St. Luke's-Roosevelt Hospital CenterCompleted
-
University of British ColumbiaUnknownInflammatory Response | Cognitive Function | Leukocytosis | TriglyceridesCanada
-
Eastern Mediterranean UniversityCompletedCardiovascular DiseasesCyprus
-
Cedars-Sinai Medical CenterCompletedPostoperative IleusUnited States
-
University of ChileSociété des Produits Nestlé (SPN)Completed
-
Assistance Publique - Hôpitaux de ParisRecruitingADCY5-related DyskinesiaFrance
-
West German Center of Diabetes and HealthTchibo GmbHCompleted
-
Massachusetts Eye and Ear InfirmaryCompleted
-
National Institute of Diabetes and Digestive and...Beth Israel Deaconess Medical Center; Harvard School of Public Health (HSPH)CompletedOverweightUnited States